BB Biotech AG 13D and 13G filings for MacroGenics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 2:39 pm Unchanged |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 9,929,963 15.800% |
0 (Unchanged) |
Filing |
| 2024-02-13 06:13 am Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 9,929,963 16.000% |
1,000,000 (+11.20%) |
Filing |
| 2023-02-14 4:09 pm Purchase |
2022-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 8,929,963 14.500% |
1,654,399 (+22.74%) |
Filing |
| 2022-02-11 4:38 pm Purchase |
2021-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 7,275,564 11.900% |
1,250,000 (+20.74%) |
Filing |
| 2021-06-11 5:25 pm Purchase |
2021-06-09 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 6,025,564 10.000% |
1,210,000 (+25.13%) |
Filing |
| 2021-02-12 4:40 pm Purchase |
2020-12-31 | 13G | MacroGenics, Inc. MGNX |
BB Biotech AG | 4,815,564 8.600% |
296,405 (+6.56%) |
Filing |